Highlights
- In genomics or specialised oncology tests there are niche areas which can further growth but larger corporates still need to look into such niche products
- Medicines are trying to move to the patients’ bedside. So we need to be cost friendly
- We need to move towards becoming more patient friendly labs
- Opportunities for the diagnostics industry are huge. However, we should make country specific strategies
Watch Full Session Video: